Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Eating fewer calories may slow skin aging and improve skin health through various biological changes.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Certain small molecules can help regrow hair by turning on the body's cell cleanup process.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

High mTORC1 activity slows hair growth and causes it to lose color.

Most women with weird scalp feelings had neck spine problems, and some got better with gabapentin treatment.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Body-hair transplant successfully improved scarred areas and frontal hair density without visible chest scarring.

FLCN helps control iron levels in cells.

Keratosis pilaris is a common skin condition causing a bumpy texture, sometimes linked to other diseases, with various treatments available.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Non-surgical procedures can help reduce wrinkles and stimulate skin repair by understanding skin aging at the molecular level.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Cyclosporin A helps damaged hair follicles regrow hair quickly.